Deep Track Capital as of Sept. 30, 2023
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 63 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 5.8 | $152M | 6.0M | 25.25 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.7 | $147M | 1.1M | 129.44 | |
| Intra Cellular Therapies (ITCI) | 5.2 | $135M | 2.6M | 52.09 | |
| Ionis Pharmaceuticals (IONS) | 5.0 | $129M | 2.8M | 45.36 | |
| Guardant Health (GH) | 4.6 | $120M | 4.1M | 29.64 | |
| Immunovant (IMVT) | 4.1 | $107M | 2.8M | 38.39 | |
| Alkermes SHS (ALKS) | 4.1 | $106M | 3.8M | 28.01 | |
| Dynavax Technologies Corp Com New (DVAX) | 3.9 | $100M | 6.8M | 14.77 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.7 | $97M | 1.9M | 50.42 | |
| Pliant Therapeutics (PLRX) | 3.7 | $95M | 5.5M | 17.34 | |
| Springworks Therapeutics (SWTX) | 3.2 | $82M | 3.5M | 23.12 | |
| Axsome Therapeutics (AXSM) | 3.1 | $80M | 1.1M | 69.89 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.7 | $70M | 3.5M | 20.09 | |
| Travere Therapeutics (TVTX) | 2.5 | $66M | 7.4M | 8.94 | |
| Intellia Therapeutics (NTLA) | 2.4 | $63M | 2.0M | 31.62 | |
| Editas Medicine (EDIT) | 2.1 | $55M | 7.1M | 7.80 | |
| Geron Corporation (GERN) | 2.1 | $55M | 26M | 2.12 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.0 | $52M | 3.2M | 16.30 | |
| Apogee Therapeutics (APGE) | 2.0 | $51M | 2.4M | 21.30 | |
| Pacific Biosciences of California (PACB) | 1.9 | $50M | 6.0M | 8.35 | |
| Miragen Therapeutics (VRDN) | 1.8 | $46M | 3.0M | 15.34 | |
| Novocure Ord Shs (NVCR) | 1.6 | $40M | 2.5M | 16.15 | |
| Hillevax (HLVX) | 1.5 | $39M | 2.9M | 13.45 | |
| Repare Therapeutics Ord (RPTX) | 1.4 | $37M | 3.1M | 12.08 | |
| Agenus Com New | 1.4 | $36M | 32M | 1.13 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $35M | 2.8M | 12.73 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.3 | $35M | 15M | 2.33 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $34M | 300k | 112.50 | |
| Terns Pharmaceuticals (TERN) | 1.2 | $30M | 6.0M | 5.03 | |
| Rapt Therapeutics (RAPT) | 1.0 | $25M | 1.5M | 16.62 | |
| Beam Therapeutics (BEAM) | 0.9 | $24M | 1.0M | 24.05 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $24M | 1.3M | 17.96 | |
| Olema Pharmaceuticals (OLMA) | 0.9 | $24M | 1.9M | 12.35 | |
| Nurix Therapeutics (NRIX) | 0.9 | $24M | 3.0M | 7.86 | |
| Biosante Pharmaceuticals (ANIP) | 0.9 | $23M | 400k | 58.06 | |
| Amylyx Pharmaceuticals (AMLX) | 0.9 | $23M | 1.3M | 18.31 | |
| Biontech Se Sponsored Ads (BNTX) | 0.8 | $22M | 200k | 108.64 | |
| Dyne Therapeutics (DYN) | 0.8 | $22M | 2.4M | 8.96 | |
| Moderna (MRNA) | 0.8 | $21M | 200k | 103.29 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $19M | 2.0M | 9.82 | |
| Point Biopharma Global | 0.7 | $19M | 2.8M | 6.67 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $17M | 2.5M | 6.60 | |
| Orchard Therapeutics Spon Ads New | 0.6 | $16M | 2.0M | 7.73 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $16M | 2.8M | 5.73 | |
| Prothena Corp SHS Put Option (PRTA) | 0.5 | $12M | 250k | 48.25 | |
| Nektar Therapeutics (NKTR) | 0.4 | $11M | 18M | 0.60 | |
| Morphic Hldg (MORF) | 0.4 | $11M | 471k | 22.91 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $11M | 422k | 24.75 | |
| Acumen Pharmaceuticals (ABOS) | 0.4 | $10M | 2.5M | 4.15 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $10M | 7.7M | 1.34 | |
| Vigil Neuroscience (VIGL) | 0.4 | $9.5M | 1.8M | 5.39 | |
| Relmada Therapeutics (RLMD) | 0.3 | $8.5M | 2.8M | 3.00 | |
| Astria Therapeutics (ATXS) | 0.3 | $7.7M | 1.0M | 7.46 | |
| 10x Genomics Cl A Com (TXG) | 0.3 | $7.5M | 183k | 41.25 | |
| Novavax Com New (NVAX) | 0.3 | $7.2M | 1.0M | 7.24 | |
| Acelyrin (SLRN) | 0.2 | $5.6M | 551k | 10.17 | |
| Gh Research Ordinary Shares (GHRS) | 0.2 | $5.0M | 499k | 10.05 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.1 | $3.3M | 829k | 3.95 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $2.5M | 354k | 7.10 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $2.4M | 328k | 7.40 | |
| Heron Therapeutics (HRTX) | 0.1 | $2.1M | 2.1M | 1.03 | |
| 89bio (ETNB) | 0.1 | $1.4M | 91k | 15.44 | |
| Century Therapeutics (IPSC) | 0.0 | $1.1M | 543k | 2.00 |
